Real-world American study of 91,134 people finds one dose of Pfizer/Moderna protects MUCH LESS against death/hospitalization then two doses in 3 or 4 week intervals.
The finding should raise questions about Canada delaying doses 16 weeks.
Some health officials, including @Healthmac defend the delay pointing to a less robust study that counted as one-shot immunized those who had a dose but who were hospitalized or died before the two weeks that shot needs to build an immune response but now the verdict is in...
2/X
The new study did NOT count people as having gotten one dose unless they were fine for 2 weeks before illness began. Those who got sick in the first two weeks were counted as not vaccinated at all. The one-dose group was limited to those who were health 2+weeks after 1st dose
3/X
The new American study was not only large and robust but also one that better represented the population as a whole with a focus on effectiveness after both one dose alone and two dose. It is the best evidence available and public health in Canada should take heed. 4/X
The American study tracked hospitalizations and deaths for 11 weeks and while one shot alone cause rates to plateau, it did so at a level considerably above the group who received two shots in 3 or 4 weeks. 5/X
Among 23,139 Americans who received both doses, one died. Among 4,058 who received only one dose and were fine the next two weeks, five died, and while that difference might seem small, it's not when multiplied by the millions of Canadian waiting 16 weeks for a 2nd shot.
6/X
None of the math or science changes the fact that Canada is far behind the US in securing timely vaccines, and that shortage creates tough choices; we can't get everyone two doses quickly. But this study should drive public health to do two things ...
7/X
Canadians w/high-risk health conditions such as diabetes, Crohn's disease and obesity (and not just morbidly obesity) should get their 2nd doses much sooner than 16 weeks, because other studies show they are far more vulnerable medrxiv.org/content/10.110… nejm.org/doi/pdf/10.105…
8/X
Dr. Tam @CPHO_Canada earlier today said Canada might re-open this summer w/20% of people getting two doses.
She needs to review the new American study and revise her approach. One dose is significantly less effective, and if we ignore that, we risk a 4th Fall wave. #COVID19
9/9
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1/2 Public Health and private vigilance in Ontario is our 1st line of defence against #coronavirus If it falls short, we face a crisis. Epidemiologists estimate between 40 and 70% of adults will eventually get coronavirus. Even at the low end, that's 4 million people infected.
2/2/a If we borrow data from China, 20% of those infected needed hospitalizations. That works out to 800,000 hospitalizations in Ontario. Even if we cut that in half, that's 400,000 needing spaces in hospitals already so full, patients are treated in hallways ...
2/2/b So public health and private vigilance must slow the spread so hospitalizations gets stretched out over many months.
My analysis springs from that for Massachusetts by director of the @HarvardGH@ashishkjha - but #onpoli bed shortage is much worse
1/4 #SuperTuesday - (1) @JoeBiden is frontrunner, having swept the South, even edging @BernieSanders in Latino-heavy Texas, beating @BernieSanders twice in his New England backyard, winning in the prairies in Oklahoma and GOP-dominant Alaska and keeping close behind in California
(2) If this dynamic continues, Biden will win the nomination by a comfortable margin; the only places I seeing him getting beat by Sanders is the Sunbelt, where Bernie has won Nevada, Colorado and Utah, and perhaps the Pacific Northwest. Everyplace else is Biden land.
(3) That's a BIG "if" as dynamic can and do change. Now that Biden is frontrunner, he becomes the focus. He has a lengthy political history to attack and has shown himself vulnerable on the hustings by his struggles to speak clearly. The next debate, he will be under full assault